429 related articles for article (PubMed ID: 6189774)
21. [Present status of tumor markers].
Hirai H
Hum Cell; 1988 Mar; 1(1):1-9. PubMed ID: 2484806
[TBL] [Abstract][Full Text] [Related]
22. [Early diagnosis of cancer using monoclonal antibodies].
Ohkura H
Nihon Rinsho; 1985 Jul; 43(7):1525-34. PubMed ID: 2414489
[No Abstract] [Full Text] [Related]
23. [Clinical significance of present tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
[TBL] [Abstract][Full Text] [Related]
24. [Significance of tumor markers in clinical oncology].
Gericke D; Drahovsky D
Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
[No Abstract] [Full Text] [Related]
25. [An overview of tumor markers].
Morita R; Fukunaga M; Ohtsuka N
Rinsho Hoshasen; 1986 Jan; 31(1):1-10. PubMed ID: 2422414
[No Abstract] [Full Text] [Related]
26. [Limitation of clinical usefulness of tumor marker].
Ishii M
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1139-45. PubMed ID: 7544963
[TBL] [Abstract][Full Text] [Related]
27. [Tumor markers--current problems in clinical application].
Yachi A
Rinsho Byori; 1982 May; 30(5):488-91. PubMed ID: 6182314
[No Abstract] [Full Text] [Related]
28. [Tumor markers. Current use in antineoplastic strategy].
Manguso L; Musset M; Coraggio F; Grimaldi G; Zito GA; Gattoni A; Catalano G; Astarita C; Papaleo G; Di Domenico M
Clin Ter; 1984 Aug; 110(3):231-41. PubMed ID: 6207976
[No Abstract] [Full Text] [Related]
29. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
[No Abstract] [Full Text] [Related]
30. Tumor markers in testis tumors.
Kansu E
Turk J Pediatr; 1984; 26(1-4):277-83. PubMed ID: 6085661
[No Abstract] [Full Text] [Related]
31. [Laboratory tests for the diagnosis and follow-up of cancer].
Stenman UH
Duodecim; 1986; 102(9):525-33. PubMed ID: 2424709
[No Abstract] [Full Text] [Related]
32. Biochemical markers in prostatic cancer.
Schacht MJ; Garnett JE; Grayhack JT
Urol Clin North Am; 1984 May; 11(2):253-67. PubMed ID: 6203205
[TBL] [Abstract][Full Text] [Related]
33. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in humans.
Focan C; Focan-Henrard D; Collette J; Mechkouri M; Levi F; Hrushesky W; Touitou Y; Franchimont P
Anticancer Res; 1986; 6(5):1137-44. PubMed ID: 2432830
[TBL] [Abstract][Full Text] [Related]
35. Historical development and potential uses of tumor antigens as markers of human cancer growth.
Gold P; Shuster J
Cancer Res; 1980 Aug; 40(8 Pt 2):2973-6. PubMed ID: 6249494
[TBL] [Abstract][Full Text] [Related]
36. [Application of mouse monoclonal antibody to the diagnosis of cancer].
Takahashi T; Ueda R
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2015-22. PubMed ID: 2424372
[TBL] [Abstract][Full Text] [Related]
37. [Current aspects of tumor immunology].
Donat H; Schiller S
Zentralbl Gynakol; 1986; 108(19):1153-63. PubMed ID: 2433851
[TBL] [Abstract][Full Text] [Related]
38. [Serodiagnosis: tumor marker].
Yoneshima M; Hattori N; Sawabu N
Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis of tumors with the use of immunologic tumor markers].
Vorlaender KO
Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
[No Abstract] [Full Text] [Related]
40. Diagnostic significance of tumor markers.
von Kleist SU
Cancer Res; 1980 Aug; 40(8 Pt 2):2977-8. PubMed ID: 6156757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
